Etablissement Francais du Sang

Etablissement Francais du Sang is a public body in La Plaine Saint Denis, France that has taken part in 17 EU-funded projects since 2009, receiving €10.9M in EU funding and leading 1 as coordinator.

EU funding received€10.9M
EU projects17
As coordinator1
Running now3
First EU project2009
Latest project2026
CountryFrance
EU registration (PIC)997299293
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Etablissement Francais du Sang's own share of each project, not the project's full budget.

  • Horizon 2020€5.4M · 9 projects
  • FP7 (2007 to 2013)€2.5M · 3 projects
  • European Defence Fund (EDF)€1.9M · 2 projects
  • Horizon Europe€934k · 1 project
  • 3rd Health Programme€57k · 1 project
  • EU4Health Programme (EU4H)€56k · 1 project

Projects

17 EU-funded projects, newest first. Etablissement Francais du Sang led 1 of them as coordinator. Each links to the official record.

  • RESILIENCE-D-2025Partner

    Second development SGA action for Medical Counter Measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium

    European Defence Fund (EDF) · 2026–2029 · Project on the EU portal ↗

    €1.9Mtheir share
  • RESILIENCEPartner

    European Strategic alliance for research, development and innovation on medical countermeasures against CBRN threats

    European Defence Fund (EDF) · 2024–2027 · Project on the EU portal ↗

  • ORTHO-ALLO-UNIONPartner

    ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non-union (ORTHO-ALLO-UNION).

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €934ktheir share
  • SUPPLYPartner

    Strengthening voluntary non-remunerated plasma collection capacity in Europe

    EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗

    €56ktheir share
  • SUPPORT-EPartner

    SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €174ktheir share
  • EVIDENCEPartner

    Erythrocytes properties and viability in dependence of flow and extra-cellular environment

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €275ktheir share
  • MEFISTOPartner

    MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €217ktheir share
  • MAXIBONEPartner

    Personalised maxillofacial bone regeneration

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €1.6Mtheir share
  • TRANSPOSEPartner

    TRANSfusion and transplantation: PrOtection and SElection of donors

    3rd Health Programme · 2017–2020 · Project on the EU portal ↗

    €57ktheir share
  • ORTHOUNIONPartner

    ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €395ktheir share
  • RESSTOREPartner

    REgenerative Stem cell therapy for STroke in Europe

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €800ktheir share
  • BIOCAPANPartner

    BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €653ktheir share
  • ADIPOA2Partner

    Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €890ktheir share
  • Ebola_TxPartner

    Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.

    Horizon 2020 · 2014–2016 · Project on CORDIS ↗

    €386ktheir share
  • ADIPOAPartner

    ADIPOSE DERIVED STROMAL CELLS FOR OSTEOARTHRITIS

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €635ktheir share
  • REBORNEPartner

    Regenerating Bone defects using New biomedical Engineering approaches

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €1.4Mtheir share
  • CASCADECoordinator

    Cultivated Adult Stem Cells as Alternative for Damaged tissue

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €430ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alkaline earth metals
  • artificial bone
  • biomaterials
  • bioreactors
  • cell biology
  • cells technologies
  • continuous glucose monitors
  • coronaviruses
  • dental implantology
  • dermatology
  • diabetes
  • diagnostic imaging
  • ebola
  • employment

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime